About 1,330,000 results
Open links in new tab
  1. FDA Approves YORVIPATH® (Palopegteriparatide) as the First …

    At launch, Ascendis plans to offer a suite of patient services for YORVIPATH through its U.S. Ascendis Signature Access Program (A.S.A.P.), including support navigating the treatment …

  2. YORVIPATH is ready to be prescribed - hypopara.org

    Dec 19, 2024 · Reflecting this commitment, Ascendis has established a dedicated YORVIPATH team within the U.S. Ascendis Signature Access Program ® to support the patient treatment …

  3. Patients who may benefit can include patients with: *Hyperphosphatemia *corrected calcium below target levels or symptomatic hypocalcemia *Hypercalcuria or nephrolithiasis despite …

  4. Your Guide to Yorvipath for Hypoparathyroidism - WebMD

    Feb 13, 2025 · Is Yorvipath Right for Me? Your health care provider may consider treatment with Yorvipath if you have hypoparathyroidism and have been taking calcium and vitamin D treatment.

  5. POLICY STATEMENT Prior Authorization is recommended for prescription benefit coverage of Yorvipath. All approvals are provided for the duration noted below. Because of the specialized …

  6. FDA Approves YORVIPATH® (Palopegteriparatide) as the First

    Aug 12, 2024 · At launch, Ascendis plans to offer a suite of patient services for YORVIPATH through its U.S. Ascendis Signature Access Program (A.S.A.P.), including support navigating …

  7. FDA approves hypoparathyroidism treatment Yorvipath

    Aug 14, 2024 · The company, through its U.S. Ascendis Signature Access Program, plans to offer patient services such as support for navigating treatment and financial assistance for eligible …

  8. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for YORVIPATH and any potential adverse effects on the breastfed …

  9. Yorvipath® is a parathyroid hormone analog (PTH(1-34)) indicated for the treatment of hypoparathyroidism in adults. Conventional therapy for hypoparathyroidism consists of active …

  10. Yorvipath: Dosage, side effects, price, uses, and more

    Mar 14, 2025 · Yorvipath (palopegteriparatide) is a prescription injection that treats hypoparathyroidism in adults, Learn about dosage, side effects, cost, uses, and more.